• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Ophthalmology

Anonymous board for Ophthalmology reps
Replies
5
Views
3K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
4
Views
7K
Anonymous